The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalosource (Di) Regulatory News (HALO)

  • There is currently no data for HALO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR'S DEALING

23 Oct 2013 07:00

RNS Number : 1398R
HaloSource Inc
23 October 2013
 

 

 

FOR IMMEDIATE RELEASE

23 October 2013

 

HaloSource, Inc.

("HaloSource" or "the Company")

 

DIRECTOR'S DEALING

Seattle, U.S.A. - HaloSource, Inc. (HALO.LN), the clean water and antimicrobial technology company traded on London's AIM, was notified on 22 October that Michael Ducey, Non-Executive Director, has purchased 41,665 common shares in the Company at a price of £0.15 per share. Following this purchase, Michael Ducey is now interested in a total of 330,834 common shares and 6,757 shares of restricted stock, representing approximately 0.22% of the issued shares capital of the Company.

Enquiries:

HaloSource

James Thompson, Chief Financial Officer and Director

+1 425 974 1993

 

Company PR- Buchanan

Charles Ryland/Clare Akhurst

 

 

+44 207 466 5000

 

Company NOMAD- Liberum Capital Limited

Simon Atkinson/Richard Bootle

 

+44 20 3100 2222

Notes to Editors

 

About HaloSource

HaloSource is a global company headquartered in Seattle, Washington U.S.A. that develops technologies to disinfect and purify the water we drink, play in and return to the environment.

· HaloPure® media became the first drinking water technology in 30 years to be registered by the United States Environmental Protection Agency ("USEPA"). In 2010, HaloPure® media was approved by China's Ministry of Health ("MOH") and widely recognised as the world's most stringent performance requirements for water purification, a key differentiator for our multi-national partners.

· SeaKlear® Pool and Hot Tub treatment products bring both natural biopolymers and antimicrobial applications for treating recreational water.

· HaloKlear® products employ natural biopolymers to provide water clarification on an industrial scale with dramatic reductions in ecological impact. In 2013, the Florida Department of Transportation (FDOT) added HaloKlear DPS (Dual Polymer System) as a reimbursable pay item to a list of construction water treatment Best Management Practices. It is the only all-natural, fully biodegradable polymer to be approved for this designation for use in all applicable FDOT projects. The product was also designated by the Washington State Department of Ecology in 2013 for General Use in construction and industrial applications.

HaloKlear, HaloPure, SeaKlear and HaloShield are either trademarks or registered trademarks of HaloSource, Inc. All other trademarks, brand names or product names belong to their respective holders.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGGBUUUPWGQP
Date   Source Headline
27th Feb 20197:00 amRNSResult of General Meeting
14th Feb 20197:00 amRNSProposed Disposal and Delisting from AIM
7th Feb 20197:00 amRNSUpdate in Funding Options
20th Dec 20184:30 pmRNSSuspension of trading
3rd Dec 20187:00 amRNSUpdate on Fundraising and Funding Options
26th Oct 20187:00 amRNSTrading Update
2nd Oct 201810:35 amRNSastrea is first bottle certified to reduce lead
27th Sep 20187:00 amRNSInterim Results
10th Sep 20184:04 pmRNSResult of AGM and Total Voting Rights
21st Aug 20186:09 pmRNSFundraise and Change of Adviser
26th Jul 20184:30 pmRNSBlock Listing Return
18th Jul 20187:00 amRNSRetailer Order for astrea
28th Jun 20182:46 pmRNSPosting of Annual Report
13th Jun 20187:00 amRNSAppointment of Joint Broker
9th May 20187:00 amRNSPreliminary Results
12th Apr 20187:00 amRNSResult of Special Meeting
19th Mar 20187:00 amRNSPosting of Circular
12th Mar 20182:00 pmRNSProposed Re-Domicile and Change of Name
26th Jan 20187:00 amRNSBlock Listing Return
12th Jan 20187:00 amRNSSuccessful Commercial Production of Lead Reduction
2nd Jan 20187:00 amRNSResult of AGM
27th Dec 20177:00 amRNSTrading Update
21st Dec 20177:08 amRNSPerfect Water Manufacturing Renews Excl Agreement
15th Dec 20177:01 amRNSPlacing and Subscription
15th Dec 20177:00 amRNSAppointment of Nominated Adviser and Broker
30th Nov 20175:00 pmRNSAIM Disclosure Update
31st Oct 20177:00 amRNSAppointment of Joint Broker
17th Oct 20177:00 amRNSAstrea Advisory Board
22nd Sep 20179:45 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
11th Sep 20177:00 amRNSHalf-year Report
26th Jul 20177:00 amRNSBlock Listing Return
20th Jul 20177:00 amRNSTrading Update
18th Jul 20177:00 amRNSSupply agreement
30th Jun 20174:00 pmRNSAnnual Report and Financial Statements
27th Jun 20173:37 pmRNSGrant of Options
23rd Jun 201711:05 amRNSSecond Price Monitoring Extn
23rd Jun 201711:00 amRNSPrice Monitoring Extension
22nd Jun 20175:46 pmRNSCorrection Director/PDMR Shareholding
21st Jun 20175:09 pmRNSDirector/PDMR Shareholding
21st Jun 20177:00 amRNSNew e-commerce customer agreement
20th Jun 20177:00 amRNSCompletion of Fundraising
13th Jun 20177:00 amRNSUpdate on Fundraising and Funding Options
9th Jun 20177:00 amRNSFurther Update on Fundraising
30th May 201711:00 amRNSUpdate on Fundraising and Shareholder Update
23rd May 20177:00 amRNSExecutive Director Appointment
18th May 20177:00 amRNSUpdate on Fundraising
21st Apr 20177:01 amRNSBoard Changes
21st Apr 20177:00 amRNSCompletion of Conditional Fundraising
6th Apr 20177:00 amRNSPreliminary Results
14th Feb 20177:00 amRNSPilot production of lead reduction media

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.